Drug Name and FDA Application Number | Dosage Form/Route | Strength | Marketing Status | Company |
ZANTAC 150
(NDA # 018703)
| TABLET; ORAL |
EQ 150MG BASE
|
Prescription
| GLAXOSMITHKLINE |
ZANTAC 150
(NDA # 020095)
| CAPSULE; ORAL |
EQ 150MG BASE
|
Discontinued
| GLAXOSMITHKLINE |
ZANTAC 150
(NDA # 020251)
| GRANULE, EFFERVESCENT; ORAL |
EQ 150MG BASE EQ 150MG BASE/PACKET
|
Prescription
| GLAXOSMITHKLINE |
ZANTAC 150
(NDA # 020251)
| TABLET, EFFERVESCENT; ORAL |
EQ 150MG BASE EQ 150MG BASE/PACKET
|
Prescription
| GLAXOSMITHKLINE |
ZANTAC 150
(NDA # 021698)
| TABLET; ORAL |
EQ 150MG BASE EQ 150MG BASE
|
OTC
| BOEHRINGER INGELHEIM |